Importantly, our results validate the findings from Crooks et al that patients with f-Hb in the 10–19 μg Hb/g faeces range and no IDA have a 1-year cumulative CRC risk which is below 3%. This evidence concerns the gene GSTM1 and colorectal carcinoma.